News

XOMA Royalty Corporation Announces Exciting Dividend Updates

XOMA Royalty Corporation Announces Exciting Dividend Updates

XOMA Royalty Corporation Updates Dividend Information

XOMA Royalty Corporation, a notable player in the biotechnology sector, has recently made noteworthy announcements regarding its preferred stock dividends. The company has declared cash dividends specifically for holders of its Series A and Series B Cumulative Preferred Stock, strengthening its commitment to its investors.

Details of the Cash Dividends

As per the latest announcement, holders of the 8.625% Series A Cumulative Perpetual Preferred Stock, known by the ticker XOMAP, will receive a cash dividend of $0.53906 per share. This payout signifies the corporation's ongoing dedication to return value to its shareholders.

Details for Series B Holders

In addition, those owning depositary shares equivalent to 1/1000 of a share in the 8.375% Series B Cumulative Perpetual Preferred Stock, identified by the ticker XOMAO, will receive a cash dividend of $0.52344 per share. This reflects XOMA Royalty’s consistent dividend strategy as part of its broader financial practices.

Payment Timeline for Shareholders

The preferred dividends are set to be distributed around October 15, 2025, to those who are holders of record by the close of business on October 3, 2025. Keeping shareholders informed is crucial in maintaining trust and transparency.

Understanding XOMA Royalty's Business Model

XOMA Royalty Corporation plays a pivotal role in the biotechnology ecosystem as a royalty aggregator. The goal of this organization is not just profitability, but to help biotech companies navigate the complexities of bringing health solutions to market. By acquiring future economics connected with pre-commercial and commercial therapeutic candidates, XOMA provides essential funding to these companies without diluting their equity.

Portfolio Overview

The company boasts a diverse and expanding portfolio of assets, defined as the right to receive potential future income from therapeutic candidates. This strategy allows the corporation to maintain a robust pipeline of valuable investments that align with its growth objectives.

Commitment to Innovation in Biotechnology

XOMA Royalty actively collaborates with pharmaceutical and biotech firms to support the development of cutting-edge treatments that can drastically improve human health outcomes. This nurturing of innovation is what sets them apart in a competitive field.

Investor Relations and Contact Information

For those interested in learning more about XOMA Royalty Corporation, including further financial updates or information about their portfolio, the company is available for inquiries through its investor relations contact:

Investor Contact
Juliane Snowden
XOMA Royalty Corporation
+1-646-438-9754
juilane.snowden@xoma.com

Frequently Asked Questions

What are the amounts of the declared dividends?

The declared dividends are $0.53906 for Series A shareholders and $0.52344 for Series B shareholders.

When will the dividends be paid out?

The dividends are scheduled to be paid on or about October 15, 2025.

How does XOMA Royalty support biotechnology companies?

XOMA Royalty provides funding to biotech firms, enabling them to advance their drug candidates without diluting equity.

What is the investment strategy of XOMA Royalty?

XOMA focuses on acquiring the rights to future revenue streams from innovative therapeutic candidates, ensuring a diverse asset portfolio.

How can I contact XOMA Royalty for more information?

Interested parties can reach out to Juliane Snowden at XOMA Royalty Corporation for inquiries regarding investments or corporate information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 23

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 290

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 136

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 258

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 157

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 530

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 124

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 424

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 19

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading

Top 5 Most Recently Viewed Articles

Atlanticus Holdings Celebrates Substantial Year-End Growth

Updated Category News Views 176

Impressive Financial Results for Atlanticus Holdings Atlanticus Holdings Corporation (NASDAQ: ATLC), known for empowering financial inclusivity through innovative technology, has reported remarkable achievements in its financial results for the fourth quarter and the full year ended December 31, 2024. The company served an impressive total of 3.7 million accounts,...

Continue Reading
Jonas Warrer Expands Stake in Gentoo Media: Key Insights

Updated Category News Views 262

Jonas Warrer's Strategic Move in Gentoo Media Holdings Recent transactions in the stock market have captivated the attention of many investors, particularly when they involve significant figures in the industry. One such notable event occurred when Jonas Warrer, CEO and primary insider of Gentoo Media, made headlines by acquiring a substantial number of shares in his own...

Continue Reading
Venture Global Inc. Faces Class Action Over Investor Losses

Updated Category News Views 233

Venture Global Inc. Investors Advised on Class Action For investors in Venture Global Inc. seeking justice, significant legal developments have unfolded. The company, known for its ambitious initiatives in the liquefied natural gas sector, is currently facing serious allegations in a class action lawsuit. For those who lost money in their investments, it's crucial to...

Continue Reading
Global Roaming Tariff Market Expected to Hit USD 140.3 Billion

Updated Category News Views 329

Overview of the Roaming Tariff Market Growth The Roaming Tariff Market has entered an exciting phase, anticipated to soar to USD 140.3 billion by 2032, after reaching USD 77.5 billion in 2023. Such growth, at a compound annual growth rate (CAGR) of 6.83% from 2024 to 2032, is invigorated by the widespread expansion of 5G technology and increasing global travel demand. Key...

Continue Reading
Investing Insights: Analyzing Charles Schwab's Market Position

Updated Category News Views 263

Understanding the Recent Shift in Charles Schwab's Market Position Charles Schwab's short percent of float has recently experienced a significant increase, rising by 67.5% as indicated by the latest reports. Currently, there are 22.74 million shares sold short, which accounts for 1.34% of the total regular shares available for trading. With this short interest, traders...

Continue Reading